$1.550
-0.145 (-9.36%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de XTLB por análisis de gráficos similares
Alphio's XTLB stock price prediction model matches the current X T L Biopharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.54 (-0.71%). The 1-week path is $1.53 (-1.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de X T L Biopharmaceuticals Ltd?
XTL Biopharmaceuticals Ltd is not a good buy right now due to its current price of $1.55, which is significantly below its 52-week high of $5.64 and reflects a staggering 58.91% decline over the past year. Additionally, the company's RSI is at 28.491, indicating it is oversold, but the lack of positive financial indicators such as a gross margin of 0.00% and a forward P/E of 0 raises serious concerns about its profitability and future growth potential. The main risk is the Nasdaq delisting notice, which could further depress the stock price if not resolved.
XTLB cerró en $1.55 el Friday, tras bajar -9.36%
X T L Biopharmaceuticals Ltd (XTLB) last closed at $1.55, losing -9.36%. These facts feed the 1-day and 1-week XTLB price prediction above.
Factores de la previsión
Los factores de la previsión de X T L Biopharmaceuticals Ltd (XTLB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de XTLB, ordenadas por similitud.
Análisis de estacionalidad de XTLB
Historically the probability of a positive November return for XTLB is 45.45%. August offers the highest probability of a positive month at 67.19%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de XTLB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.86 | $1.91 | $2.28 | +23.46% |
| Dec 2026 | $2.08 | $2.09 | $2.34 | +34.69% |
En 2026, se proyecta que X T L Biopharmaceuticals Ltd (XTLB) oscile entre $1.86 y $2.34.
Previsión mensual de X T L Biopharmaceuticals Ltd para 2026
En Nov de 2026, se proyecta que X T L Biopharmaceuticals Ltd promedie $1.91, con un mínimo de $1.86 y un máximo de $2.28.
En Dec de 2026, se proyecta que X T L Biopharmaceuticals Ltd promedie $2.09, con un mínimo de $2.08 y un máximo de $2.34.
Artículos relacionados
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.